| scholarly article | Q13442814 |
| P2093 | author name string | C. C. Chen | |
| C. Y. Huang | |||
| J. F. Liao | |||
| W. F. Chiou | |||
| P2860 | cites work | The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway | Q22009096 |
| TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB | Q24307620 | ||
| Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 | Q24537518 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| 8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-κB and IRF3 | Q24632804 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase | Q28137640 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 | ||
| Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction | Q28271470 | ||
| Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase | Q28278061 | ||
| DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells | Q28506839 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Proteinases in bone resorption: obvious and less obvious roles. | Q33838178 | ||
| Differentiation and function of osteoclasts | Q35113943 | ||
| Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts | Q35126799 | ||
| How proteases regulate bone morphogenesis | Q35157756 | ||
| Roles for NF-kappaB and c-Fos in osteoclasts | Q36177501 | ||
| RANKing intracellular signaling in osteoclasts | Q36191485 | ||
| Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones | Q36316526 | ||
| Fos/AP-1 proteins in bone and the immune system | Q36324940 | ||
| TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. | Q36404187 | ||
| Podosome and sealing zone: specificity of the osteoclast model | Q36424995 | ||
| The molecular understanding of osteoclast differentiation | Q36650749 | ||
| The role of NFAT in osteoclast formation | Q37033696 | ||
| NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). | Q37302319 | ||
| Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 | ||
| Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 | ||
| Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues | Q43807594 | ||
| p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function | Q44072080 | ||
| Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation | Q44398373 | ||
| Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi | Q44989505 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. | Q53959402 | ||
| Induction of DC-STAMP by Alternative Activation and Downstream Signaling Mechanisms | Q57675118 | ||
| NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1 | Q57675122 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| Bone and haematopoietic defects in mice lacking c-fos | Q58326969 | ||
| Interfering with bone remodelling | Q59083003 | ||
| Bianthrones from Senna longiracemosa | Q104390991 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 321-335 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | 2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes | |
| 2‐Methoxystypandrone represses RANKL‐mediated osteoclastogenesis by down‐regulating formation of TRAF6–TAK1 signalling complexes | |||
| P478 | volume | 161 |
| Q35099825 | (+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation |
| Q35051465 | 2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase |
| Q36801757 | A Special Ingredient (VtR) Containing Oligostilbenes Isolated from Vitis thunbergii Prevents Bone Loss in Ovariectomized Mice: In Vitro and In Vivo Study |
| Q57493373 | Low-intensity pulsed ultrasound inhibits RANKL-induced osteoclast formation via modulating ERK-c-Fos-NFATc1 signaling cascades |
| Q92062969 | Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling |
| Q36147283 | Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption? |
Search more.